These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6812036)

  • 1. Early onset life-threatening myelosuppression after low dose of intravesical thiotepa.
    Agnelli G; de Cunto M; Gresele P; del Favero A
    Postgrad Med J; 1982 Jun; 58(680):380-1. PubMed ID: 6812036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intractable bladder hemorrhage requiring cystectomy after use of intravesical thiotepa.
    Treible DP; Skinner D; Kasimain D; Friedman NB; Kern WH
    Urology; 1987 Dec; 30(6):568-70. PubMed ID: 3120389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute nonlymphocytic leukemia after thiotepa instillation into the bladder: report of 2 cases and review of the literature.
    Silberberg JM; Zarrabi MH
    J Urol; 1987 Aug; 138(2):402-3. PubMed ID: 3110436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy in superficial neoplasms of the bladder.
    Zingg E; Sulmoni A
    S Afr Med J; 1972 Jul; 46(27):916-7. PubMed ID: 4626807
    [No Abstract]   [Full Text] [Related]  

  • 5. Thiotepa-induced myelosuppression: review of 670 bladder instillations.
    Soloway MS; Ford KS
    J Urol; 1983 Nov; 130(5):889-91. PubMed ID: 6415297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracavitary chemotherapy for multiple non-invasive bladder tumours.
    Riddle PR; Wallace DM
    Br J Urol; 1971 Apr; 43(2):181-4. PubMed ID: 4996213
    [No Abstract]   [Full Text] [Related]  

  • 7. Hematologic effects of intravesicular thiotepa therapy for bladder carcinoma.
    Hollister D; Coleman M
    JAMA; 1980 Nov; 244(18):2065-7. PubMed ID: 6776297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 28-1977.
    N Engl J Med; 1977 Jul; 297(2):102-7. PubMed ID: 405588
    [No Abstract]   [Full Text] [Related]  

  • 9. Intravesical thiotepa in the treatment of transitional cell bladder carcinoma.
    Mitchell RJ
    Br J Urol; 1971 Apr; 43(2):185-8. PubMed ID: 4996214
    [No Abstract]   [Full Text] [Related]  

  • 10. Generalized hypersensitivity reaction to intravesical thiotepa and doxorubicin.
    Lee M; Sharifi R
    J Urol; 1987 Jul; 138(1):143-4. PubMed ID: 3110433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute nonlymphocytic leukemia following bladder instillations with thiotepa.
    Easton DJ; Poon MA
    Can Med Assoc J; 1983 Sep; 129(6):578-9. PubMed ID: 6411320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The harmfulness of intravesical instillations of thiotepa in cases of vesico-renal reflux].
    Rampal M; Alimi JC; Pons G; Fiquet JM
    J Urol Nephrol (Paris); 1978 Mar; 84(3):271-4. PubMed ID: 417193
    [No Abstract]   [Full Text] [Related]  

  • 13. [Thio-Tepa in the chemotherapy and chemical prevention of papillary neoplasms of the bladder].
    Delzotto L; Viggiano G; Marchini M; Barbui PE
    Minerva Med; 1977 Jun; 68(28):1957-60. PubMed ID: 406584
    [No Abstract]   [Full Text] [Related]  

  • 14. [Intraluminal visceral chemotherapy of noninfiltrating cancers of the bladder (preliminary report)].
    Mocellini Iturralde JA; Rapaport M; Montenegro L; Arrighi A
    Rev Argent Urol Nefrol; 1970; 39(7):144-51. PubMed ID: 4999227
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemotherapy for bladder cancer.
    Veenema RJ; Romas NA; Fingerhut B
    Urology; 1974 Feb; 3(2):135-9. PubMed ID: 4204755
    [No Abstract]   [Full Text] [Related]  

  • 16. [Myelodepressive effect during intracavitary cytostatic treatment of bladder tumors].
    González R; Millones A; Guzmán A; Gelabert A
    Arch Esp Urol; 1979; 32(1):49-52. PubMed ID: 109052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancytopenia and generalized sepsis following treatment of cancer of the bladder with instillations of triethylene thiophosphoramide.
    Bruce D; Edgcomb JH
    J Urol; 1967 Mar; 97(3):482-5. PubMed ID: 4960046
    [No Abstract]   [Full Text] [Related]  

  • 18. Severe pancytopenia associated with the use of intravesical thio-TEPA.
    Watkins WE; Kozak JA; Flanagan MJ
    J Urol; 1967 Oct; 98(4):470-1. PubMed ID: 4964489
    [No Abstract]   [Full Text] [Related]  

  • 19. Nephrogenic adenoma in a patient with chronic renal failure associated with intravesical treatment with thiotepa.
    Embon OM; Turani H; Gold CH; Sazbon A
    Eur Urol; 1990; 17(2):181-2. PubMed ID: 2107082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Spontaneously cured pancytopenia due to intravesical thio-tepa, apropos of one case].
    Archimbaud JP; Calcat P; Martel JP
    J Urol Nephrol (Paris); 1973 Dec; 79(12 Pt 2):487-8. PubMed ID: 4216648
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.